TITLE

INHALER DEVICES STILL A MAJOR HURDLE IN ASTHMA/COPD

PUB. DATE
July 2008
SOURCE
Worldwide Biotech;Jul2008, Vol. 20 Issue 7, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses the advantages and disadvantages of inhaler devices in the treatment of asthma and COPD. Inhaler devices have a wide variation in design and method of delivery of the drug, making it difficult for patients to learn and use them correctly. It emphasizes the need to have a range of molecules available in the same device.
ACCESSION #
32848003

 

Related Articles

  • Increased mortality with tiotropium mist inhaler.  // African Journal of Respiratory Medicine;Sep2011, Vol. 7 Issue 1, p2 

    The article focuses on the study, according to which risk of death increases among patients with chronic obstructive pulmonary disease (COPD) associated with use of a tiotropium mist inhaler.

  • Latest asthma thinking.  // Update;11/17/2005, Vol. 71 Issue 5, p23 

    The article presents key developments in the treatment of asthma. The key developments include lowering the threshold at which inhaled steroids should be introduced, more emphasis on educating patients and issuing written action plans, and a recommendation for primary care services to undergo...

  • Peak expiratory flow rate does not predict exacerbation of asthma. Tierney, WM; Roesner, JF; Seshadri, R // BMJ: British Medical Journal (International Edition);7/17/2004, Vol. 329 Issue 7458, preceding p121 

    Presents a question regarding asthma, and suggests an answer by way of a medical synopsis. Relationship between the measuring of peak expiratory flow rate and asthmatic exacerbations; Details of the study conducted to research the answer to the question of the relationship; Findings of the study.

  • A Patient with Asthma Seeks Medical Advice in 1828, 1928, and 2012. von Mutius, Erika; Drazen, Jeffrey M. // New England Journal of Medicine;3/1/2012, Vol. 366 Issue 9, p827 

    The article presents three fictional reports of consultations performed essentially for a patient with asthma in 1828, 1928, and 2012. Its aim is to illustrate the evolution of medicine's understanding of asthma's pathobiology, how to diagnose it, and how to treat it. It also wants to offer a...

  • Treatment of Mild Persistent Asthma. O'Connor, George T. // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2096 

    The article presents the third treatment option for the online Clinical Decisions Forum on the treatment of a women with mild persistent asthma. The forum allows readers to decide which treatment they think is most appropriate and why. This article focuses on once-daily combination inhaler...

  • Treatment of Mild Persistent Asthma.  // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2096 

    The article presents an introduction to the online Clinical Decisions Forum, which allows readers to express what they would do in a given clinical setting and why. The article refers to two articles published in this issue of the "New England Journal of Medicine," including the American Lung...

  • Treatment of Mild Persistent Asthma.  // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2096 

    The article presents the case vingette for the online Clinical Decisions Forum on the treatment of mild persistent asthma. The forum allows readers to express what they would do in a given clinical setting and why. In the case, a women with a lifelong history of asthma wonders whether she should...

  • Drug watch. Kaufman // Formulary;Nov99, Vol. 34 Issue 11, p974 

    Lists drugs and drug formulations used for the treatment of asthma and COPD. Anti-IgE/IgE 025A; Formoterol; Formoterol fumarate; SB 207499; Seratrodast; Tiotropium bromide.

  • Chronic asthma. Cates, Christopher // BMJ: British Medical Journal (International Edition);10/27/2001, Vol. 323 Issue 7319, p976 

    Focuses on chronic asthma, defined as an exacerbation of underlying asthma requiring urgent or emergency treatment. Incidence; Aetiology and risk factors; Prognosis; Benefits and drawbacks of various treatments, including regular and as needed use of short acting inhaled beta 2 agonists.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics